Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lilly interested in ibogaine investments, its neuro leader says

Eli Lilly is interested in R&D efforts to “improve the profile of ibogaine,” the pharma giant’s neuroscience president said at a psychedelics conference Thursday. Carole Ho, who joined the company last year from Denali Therapeutics ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 16 October →